Our Pricing

Buy Semaglutide Online UK Prescription

Looking to buy semaglutide online UK prescription service? Cured Pharmacy offers genuine Wegovy semaglutide injections from £79.00 with free online consultation completed in under 3 minutes by UK-registered prescribers. Our transparent pricing and discreet packaging make starting your weight loss journey straightforward and confidential.

How Semaglutide Works for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a body mass index of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. This medication mimics a natural hormone that regulates appetite and food intake by acting on areas of the brain responsible for hunger signals.

The STEP clinical trial programme demonstrated that semaglutide 2.4mg weekly injections led to an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Participants also experienced improvements in cardiovascular risk factors including blood pressure, cholesterol levels, and glycaemic control. Semaglutide slows gastric emptying and enhances feelings of fullness, helping patients reduce calorie intake naturally whilst maintaining nutritional balance [2].

Wegovy Semaglutide Dosing Schedule

Wegovy follows a graduated dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising therapeutic response [3]. Treatment begins with 0.25mg once weekly for four weeks, then increases progressively through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly.

This gradual titration allows your body to adapt to the medication's effects on gastric emptying and appetite regulation. Each dose is administered via a pre-filled, single-use pen injector into the abdomen, thigh, or upper arm. Your UK prescriber will provide detailed injection technique guidance during your consultation, and you'll receive written instructions with your first prescription.

What to Expect During Dose Escalation

Most patients tolerate the dose increases well when combined with dietary modifications. Mild nausea is the most commonly reported side effect during the first 4-8 weeks, typically resolving as treatment continues [3]. Eating smaller portions, avoiding high-fat meals, and staying well-hydrated can significantly reduce gastrointestinal symptoms. If you experience persistent side effects, your prescriber may adjust the escalation timeline to suit your individual tolerance.

Clinical Evidence: STEP Trial Results

The Semaglutide Treatment Effect in People with Obesity (STEP) programme comprised five phase 3 randomised controlled trials involving over 4,500 participants across multiple countries [1][4]. STEP 1, the largest trial, enrolled adults with obesity or overweight plus weight-related comorbidities who were not diabetic.

Results showed that 86.4% of participants on semaglutide 2.4mg achieved at least 5% body weight loss, compared to 31.5% on placebo [1]. Furthermore, 69.1% achieved 10% or greater weight reduction, and 50.5% lost 15% or more of their baseline body weight. These outcomes were accompanied by significant improvements in cardiometabolic risk factors, including reductions in waist circumference averaging 13.54cm and improvements in systolic blood pressure [4].

Long-term data from STEP 5 demonstrated sustained weight loss over 104 weeks, with participants maintaining an average 15.2% body weight reduction when treatment continued [5]. These findings establish semaglutide as one of the most effective pharmacological interventions for obesity management currently available in the UK.

Who Can Use Semaglutide for Weight Loss

Semaglutide is licensed in the UK for adults aged 18 and over with a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [2]. Your UK prescriber will calculate your BMI during the online consultation and assess your medical history to determine suitability.

Certain medical conditions preclude semaglutide use. You cannot use this medication if you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or if you're pregnant, breastfeeding, or planning pregnancy [3]. Patients with severe gastrointestinal disease, including inflammatory bowel disease or diabetic gastroparesis, require careful assessment before treatment initiation.

Contraindications and Precautions

Your prescriber will review your current medications for potential interactions. Semaglutide may delay gastric emptying, potentially affecting the absorption of oral medications, particularly those requiring rapid onset such as analgesics or antibiotics. If you're taking insulin or sulfonylureas, dose adjustments may be necessary to prevent hypoglycaemia. Patients with a history of pancreatitis, severe renal impairment, or retinopathy require additional monitoring during treatment [2][3].

How to Buy Semaglutide Online UK Prescription Service

At Cured Pharmacy, accessing semaglutide begins with a free online consultation that takes under 3 minutes to complete. You'll answer medical questions about your weight history, current medications, and relevant health conditions. Our UK-registered prescribers, working under the clinical governance of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), review every consultation individually.

If semaglutide is deemed clinically appropriate for you, your prescription is issued electronically and sent directly to our dispensary. We source all medications from UK-licensed wholesalers, ensuring you receive genuine Wegovy pens manufactured by Novo Nordisk. Your treatment is dispatched in discreet, unmarked packaging with next-day delivery options available. Pricing is transparent from the outset—you'll see the exact cost before completing your consultation, with Wegovy starting from £79.00.

Follow-up care is integral to our service. You'll have access to our clinical team throughout your treatment journey for dosing queries, side effect management, or prescription renewals. We recommend regular monitoring of your weight loss progress and scheduling reviews every 12 weeks to assess treatment efficacy and adjust your care plan as needed.

Managing Side Effects and Maximising Results

Gastrointestinal symptoms including nausea, diarrhoea, constipation, and abdominal discomfort are the most frequently reported side effects, typically occurring during dose escalation [3]. These effects are generally mild to moderate and diminish over time. To minimise discomfort, eat smaller, more frequent meals, avoid lying down immediately after eating, and choose foods lower in fat and refined carbohydrates.

Semaglutide is most effective when combined with lifestyle modifications. Clinical trials included dietary counselling and increased physical activity as standard interventions [1][4]. Aim for a 500-600 calorie daily deficit through balanced nutrition rather than extreme restriction. Incorporate at least 150 minutes of moderate-intensity aerobic activity weekly, alongside resistance training to preserve lean muscle mass during weight loss.

Rare but serious side effects include pancreatitis, gallbladder disease, and acute kidney injury, particularly in patients experiencing severe vomiting or diarrhoea leading to dehydration [2][3]. Seek immediate medical attention if you develop severe persistent abdominal pain, especially if radiating to the back, or signs of dehydration such as decreased urination, dizziness, or confusion. Your prescriber will provide comprehensive safety information with your first prescription.

When to Contact Your Prescriber

Contact our clinical team if you experience persistent nausea lasting beyond the first month, recurrent vomiting preventing adequate hydration, or if you're unable to tolerate dose increases. We can adjust your titration schedule or provide additional support strategies. If you're not achieving at least 5% weight loss after 12-16 weeks on the maintenance dose, your prescriber will reassess your treatment plan, as continued use may not be clinically justified without adequate response [2].

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/13799
3. Novo Nordisk. (2023). Wegovy (semaglutide) injection: Prescribing Information. Retrieved from https://www.novonordisk.com/content/dam/nncorp/global/en/our-products/documents/wegovy-prescribing-information.pdf
4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
5. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment and lifestyle modifications.